MassDevice Q&A: Susan Windham-Bannister, Part II

March 2, 2009 by Brian Johnson

The second installment of a long conversation with Susan Windham-Bannister, head of the Massachusetts Life Sciences Center.

Susan Windham-Bannister. Photo by Kimberly Moa.

The Massachusetts Life Sciences Center cuts a high profile these days. Created by the state Legislature in June 2006 to foster research and economic development in the Commonwealth’s substantial life science sector, the center has money to burn, thanks to the Life Sciences Act the Bay State passed last year.

Led by Susan Windham-Bannister, a former healthcare policy wonk turned business strategy consultant turned state life sciences czar, the quasi-public agency is charged with dispensing a mix of public and private funding to cultivate the state’s medical device, biotech and pharmaceutical sectors.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA Database Search


FDAzilla

Search the FDA's 510(k) and PMA database instantly.

Features

Soteira CEO Larry Jasinski talks to MassDevice about overcoming the odds with spinal fusion devices and managing a 510(k) win even after the FDA switched things up mid-stream.

Medtronic CEO Omar Ishrak tells MassDevice.com about how he screens potential acquisitions, his plan to re-shape the company and handling the controversy over the Infuse spine treatment.

MassDevice goes one-on-one with the senior VP of Abbott Medical Optics and the chairman of AdvaMed about the state of the device industry.

Sen. Scott Brown, the junior senator and Republican from Massachusetts, garners big bucks in campaign donations from med-tech makers as he rallies against the device tax and gears up for re-election.

Alfred Mann Foundation CEO David Hankin tells MassDevice how to make an artificial nervous system using microstimulators that communicate wirelessly through the body.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp